RecruitingNCT07069673

Abbott Cephea Mitral Valve Disease Registry

Sponsor

Abbott Medical Devices

Enrollment

1,000 participants

Start Date

Aug 13, 2025

Study Type

OBSERVATIONAL

Conditions

Mitral Regurgitation Mitral Stenosis Mitral Valve Disease Mitral Annulus Calcification Mitral Valve Replacement Mitral Valve (MV) Regurgitation Transcatheter Valve Replacement

Summary

The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of correcting symptomatic mitral valve disease on clinical outcomes in patients that could be candidates for Transcatheter Mitral Valve Replacement and may also inform future regulatory or reimbursement submission strategies for the Cephea Mitral Valve System.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with mitral annulus calcification, mitral regurgitation, and other related conditions. The study is currently recruiting participants at 23 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(23)

University Hospital - Univ. of Alabama at Birmingham (UAB)

Birmingham, Alabama, United States

Phoenix Cardiovascular Research Group

Phoenix, Arizona, United States

Los Robles Regional Medical Center

Thousand Oaks, California, United States

Piedmont Heart Institute

Atlanta, Georgia, United States

Emory University Hospital

Atlanta, Georgia, United States

Northwestern Memorial Hospital

Chicago, Illinois, United States

Ascension St. Vincent

Indianapolis, Indiana, United States

Via Christi Regional Medical Center - St. Francis Campus

Wichita, Kansas, United States

Minneapolis Heart Institute

Minneapolis, Minnesota, United States

Providence St. Patrick Hospital

Missoula, Montana, United States

St. Francis Hospital

Roslyn, New York, United States

Montefiore Medical Center - Moses Campus

The Bronx, New York, United States

Atrium Health - Carolinas Medical Center

Charlotte, North Carolina, United States

The Cleveland Clinic Foundation

Cleveland, Ohio, United States

Allegheny General Hospital - ASRI

Pittsburgh, Pennsylvania, United States

Medical University of South Carolina

Charleston, South Carolina, United States

TriStar Centennial Medical Center

Nashville, Tennessee, United States

Ascension Saint Thomas

Nashville, Tennessee, United States

Vanderbilt Heart & Vascular Institute

Nashville, Tennessee, United States

Houston Methodist

Houston, Texas, United States

UTHealth Memorial Hermann

Houston, Texas, United States

Intermountain Medical Center

Murray, Utah, United States

Sentara Norfolk General Hospital

Norfolk, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07069673

Related Trials

MitrAl Valve Calcium aSsEssmEnt With TrueVue Trans-illumination 3D Rendering.

NCT076125531 location

Capstan Medical TMVR Study: FIH

NCT066001913 locations

A Clinical Study Evaluating the Replacement of the Native Mitral Valve Using the ReValve System

NCT074509113 locations

Cephea Early Feasibility Study

NCT0506100422 locations

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

NCT0549699837 locations